Issuu on Google+

Stock Ticker : TEVA Exchange : NYSE Sector : Drug Manufacturers - Major Report date : Fri May 09 07:58:00 EDT 2014

Industry overview

Market Cap Market Cap is the price of all the outstanding common shares if we were to buy it all at the current price

41.29B

The benchmark company (Pfizer) in the drug manufacturers - major sector is 477 times the size of Teva Pharmaceutical Industries Limited

Large Caps are a choice for people who want Low volatility/risk with stable returns and high liquidity

1


Stock Analysis Growth Analysis Companies that have grown historically are more likely to exibit similar growth in the future. Read the trends in the 4 year annualized profit growth, book value growth and sales growth shown below:

KEY

How good are the returns? RoE is the speed at which the company might grow without sorting to additional fund raising. RoA gives an idea as to how efficient management is at using its assets to generate earnings. The 2-year and 4-year values give a reasonable assurance about the growth sustenance.

KEY

2


Piotroski Score Seperate Winners from Losers The Piotroski scoring system is a nine point system to determine the strength of a firm's financial position. The score was developed by an accounting professor out of Chicago named Joseph Piotroski. If it scores an 8 or 9, then the fundamentals are great for the stock.

Score: 6/9

3


get more @ goodinvestory.com

DISCLAIMER This report is prepared by the good.inve.story. software and is not prepared by an actual person who has a CFA or any other certification. good.inve.story. is still in BETA mode. So, please let us know if you find any errors. We would love to hear from you. This report is based on information obtained from public sources and sources believed to be reliable, but no independent verification has been made nor is its accuracy or completeness guaranteed. This report is not an advisory to buy or sell. Please buy only if you think, this is the right company at the right price and sell only if you don’t see any potential for upside.

4


Teva pharmaceutical industries limited